Founded: 2014, Rio de Janeiro, Brazil
The redeLEISH Network brings together leishmaniasis experts in Latin America to increase collaboration and maximize existing resources and expertise in areas where serious gaps exist.
The network promotes the sharing of information on treatment, diagnosis, and development of clinical trial design for cutaneous leishmaniasis. It also enables the exchange of technical and scientific knowledge among participants, and it contributes to the implementation of strategic policies and research priorities. Through the mapping of possible research centers and the implementation of training in Good Clinical Practice, redeLEISH also strengthens institutional capacity for clinical research.
redeLEISH comprises more than 70 representatives from over 38 institutions in 8 Latin American countries [Bolivia, Brazil, Colombia, Guatemala, Mexico, Peru, Panama, Venezuela].
A web forum facilitates the exchange of information and technical discussions to support the implementation of clinical trials in the region. It was created in 2015 as a virtual tool to integrate its members and to promote dialogue among them, as well as to update the progress and implementation of clinical trials, provide documents and publication sharing and generate discussions on the challenges in the development of and access to treatments for CL.
The Network is active in:
- Treatments & access
- Clinical trials
- Capacity strengthening
- Originally created as a Brazilian network of investigators, in 2015, redeLEISH was extended to include reference centres and experts from other Latin American countries.
- The second meeting was held in Medellin, Colombia, with the collaboration of PECET (Program for the Study and Control of Tropical Diseases/ University of Antioquia), and Ruta N Medellin. This meeting had more than 65 representatives from 35 institutions, among them 17 reference centers from 8 countries (Brazil, Colombia, Peru, Panama, Guatemala, Venezuela, Bolivia and Mexico), representatives of PAHO, TDR/WHO, FIOCRUZ, and of the Colombian and Brazilian Ministries of Health to identify the capacity of clinical research in Latin America and to consolidate the framework of collaborative projects. Furthermore, the agenda included a discussion towards the target product profile of a rapid diagnostic test for CL
- A Webforum was created, to act as a virtual platform that could serve as a real space to share experiences in leishmaniasis.
Contact Mady Barbeitas: email@example.com